How can small firms benefit from open innovation? the case of new drug development in Taiwan

Yu Shan Su*, Hsin Yi Hu, Feng Shang Wu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'How can small firms benefit from open innovation? the case of new drug development in Taiwan'. Together they form a unique fingerprint.

Social Sciences

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Economics, Econometrics and Finance

Chemical Engineering